July 9, 2021 Clinical Research/Diagn.

GE Healthcare to Offer End-To-End Deep Learning Solutions with Spectronic Medical to Improve Accuracy for Radiation Oncology Treatment

Chicago/Helsingborg, Sweden July 9, 2021:  GE Healthcare announces the integration of Spectronic Medical AB AI-based software[1] for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.... Read more

July 9, 2021 Clinical Research/Diagn. PAI Top-10

WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis

Tuberculosis is a disease of poverty, and economic distress with 1.4 million deaths annually1 and the growing challenge of drug resistance is adding to the global health crisis WHO guidelines support the expansion of tuberculosis diagnostics in resource-limited countries, enabling patients to receive timely diagnosis leading to proper treatment, which benefits their recovery and slows... Read more

July 7, 2021 Clinical Research/Diagn.

GE Healthcare’s Industry-First Contrast-Guided Biopsy Solution, Serena Bright, Installed in Five Major Hospitals in the United States

Serena Bright™ sets new standards for breast cancer detection and biopsy technology CHICAGO, IL July 7, 2021:  GE Healthcare today announced the installation of Serena Bright™ in five hospitals and radiology centers around the United States. Serena Bright™ is the industry’s first contrast-guided biopsy solution, helping empower clinicians and patients in their fight against breast... Read more

July 7, 2021 Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics Center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine SAN JOSE, Calif. and DAVIS, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving... Read more

July 7, 2021 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics

Exclusive agreement to provide Thermo Scientific MAS Quality Controls for VITROS Analyzers FREMONT, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS... Read more

June 25, 2021 Clinical Research/Diagn. PAI Top-10

Teen Scientist Creates Novel Diagnostic Tool for Inflammatory Bowel Disease (IBD)

From May 16 to May 21, 2021, nearly 2,000 young scientists, engineers, entrepreneurs and inventors convened virtually for a week of connecting with their peers and global STEM leaders, events, and $5 million in awards and prizes. The finalists, selected from nearly 400 affiliate fairs in 64 countries, regions and territories, have all completed exemplary... Read more

June 25, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy PR/Corporate

Roche’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children

The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more

June 23, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Tecan expands its commercial reach, its capabilities and its US and Asia presence with the acquisition of Paramit Corporation

Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million)  In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs  Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing  Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast-growing medical... Read more

June 16, 2021 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology CARLSBAD, Calif., June 16, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular... Read more

June 14, 2021 Clinical Research/Diagn. Lab Top-10 Product Launch

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021 Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months WALTHAM, Mass., June 14, 2021 /PRNewswire/ — BIO DIGITAL 2021 – New... Read more